Stopping SSRIs: what you need to know

Many people take an antidepressant from the SSRI group for months or years — and at some point the question arises: how do I stop again? Anyone who stops too quickly or abruptly risks unpleasant discontinuation symptoms. This guide explains why you should never stop SSRIs abruptly, how tapering works, and how to tell discontinuation symptoms apart from a relapse.

1. What are SSRIs and how do they work?

SSRI stands for selective serotonin reuptake inhibitors — one of the most frequently prescribed groups of antidepressants. They are used for depression, anxiety disorders, obsessive-compulsive disorders and other conditions. Well-known active ingredients are sertraline, citalopram, escitalopram, paroxetine and fluoxetine.^¹

SSRIs increase the availability of the messenger substance serotonin in the brain by inhibiting its reuptake into the nerve cells. Over weeks, this leads to adaptation processes that make up the antidepressant effect. It is precisely this adaptation of the brain to the medication that is also the reason why stopping has to happen gradually: the body has become accustomed to the active ingredient and needs time to readjust.

Important: SSRIs are not "addictive" in the sense of a dependence with craving and dose escalation. However, a physical habituation does develop, which is why temporary symptoms can occur when stopping. That is an important difference, which we explain in this guide.

2. Why you should not stop SSRIs abruptly

The most important message of this guide: SSRIs must not be stopped abruptly. If the medication is left out suddenly, a discontinuation syndrome can occur — the body reacts to the sudden loss of the active ingredient it has become used to.^²

• The body needs time to readjust: the brain has adapted over weeks to the raised serotonin level — a sudden loss overwhelms this adaptation
• Discontinuation symptoms: the more abrupt the stopping, the more likely and more severe the symptoms (its own chapter)
• Relapse risk: stopping too early or too quickly can also raise the risk of a relapse of the underlying condition
• Uncertainty: unexpected discontinuation symptoms are often misread as a relapse (its own chapter)

That is why: stopping happens slowly, gradually and with medical supervision. Even someone who feels well and "no longer needs" the medication should not simply leave it out, but plan the exit with their doctor. This applies, by the way, not only to SSRIs but to antidepressants in general.

3. The discontinuation syndrome: typical symptoms

The SSRI discontinuation syndrome covers a range of symptoms that can occur after stopping too quickly or after a dose reduction. They usually begin within a few days and are as a rule temporary:^²

• Flu-like symptoms: fatigue, aching limbs, headache, sweating
• Dizziness and balance problems
• "Brain zaps": brief, electric or flash-like sensations in the head — a typical, often unsettling discontinuation symptom
• Sleep problems, vivid or unpleasant dreams
• Nausea, gastrointestinal complaints
• Mood swings, irritability, anxiety, inner restlessness
• Abnormal sensations such as tingling
• Concentration and balance problems

The symptoms are summarized with the English mnemonic "FINISH" (Flu-like, Insomnia, Nausea, Imbalance, Sensory disturbances, Hyperarousal). They are unpleasant, but as a rule not dangerous and usually subside with slow tapering. Some people have hardly any symptoms, others more pronounced ones — this is very individual.

4. Discontinuation syndrome or relapse? The difference

A particularly important distinction — because discontinuation symptoms are often wrongly interpreted as a relapse of depression, which leads to unnecessary uncertainty:^²

• Time course: discontinuation symptoms usually begin quickly (within days of the reduction); a real relapse of depression typically develops more slowly (over weeks)
• Type of symptoms: discontinuation symptoms often involve physical complaints such as dizziness, brain zaps and flu-like symptoms, which are untypical for depression
• Response to the dose: discontinuation symptoms often improve quickly when the previous dose is taken again — a relapse not as quickly
• Duration: discontinuation symptoms are usually temporary (days to a few weeks); a returning depression persists

This distinction is important because it determines the further course of action: with discontinuation symptoms, the tapering pace can be slowed down; with a threatening relapse, the therapy may have to be continued or adjusted. This is exactly why stopping should be medically supervised — the doctor can best assess what is going on here.

5. When is the right time to stop?

Whether and when an antidepressant can be stopped is a medical decision that depends on many factors:

• Stability: the symptoms should have been stably improved over a sufficiently long period before stopping is considered
• Duration of treatment: after a first depressive episode, therapy is often continued for a certain time after improvement to avoid relapses — longer with repeated episodes
• Life situation: a stable, ideally low-stress phase of life is more favourable for stopping than a stressful one
• Individual history: the number of previous episodes, severity and relapse risk play a role

The right time is determined together with the doctor. Stopping too early raises the relapse risk — which is why patience is important. Many people stop too early because they feel well, and then experience a relapse. Continuing beyond the acute improvement is often part of the treatment.

6. How tapering works

Tapering means reducing the dose step by step over a longer period, instead of stopping the medication suddenly. This way the body can adapt:^²

• Gradual reduction: the dose is reduced in several steps over weeks (often months too)
• Individual pace: how quickly it is reduced depends on the active ingredient, the dose, the duration of use and tolerability
• Watch for symptoms: if discontinuation symptoms occur, the next step is delayed or made smaller
• Patience: tapering too quickly is the most common reason for discontinuation symptoms — better to go slower
• Medically supervised: the doctor sets the reduction plan and adjusts it when needed

There is no "standard schedule" that fits everyone — tapering is adjusted individually. What matters is the principle: better too slow than too fast. For people who have problems with standard schedules, hyperbolic tapering comes into play (next chapter).

7. Hyperbolic tapering when there are problems

An increasingly noted approach for people who have difficulties with normal tapering. With hyperbolic tapering, the dose is reduced in ever smaller steps — especially at the end, at the low doses:^²

• Background: the effect at the serotonin transporter rises particularly steeply at low doses — this means that even small dose reductions at the lower end have a large effect
• Consequence: the last steps (from a low dose to zero) have to be especially small and slow — not simply "leaving out half the dose"
• Very small steps: sometimes this requires special dosage forms (drops, solutions) or the preparation of small dose steps — always with medical/pharmacist supervision
• Longer period: tapering can thus stretch over many months, but is more tolerable as a result

This approach is especially important for people who have experienced strong discontinuation symptoms with reduction steps that were too coarse. It should be medically supervised, since the exact implementation (very small dose steps) requires expertise. Talk to your doctor about it if normal tapering does not work for you.

8. Differences between the individual SSRIs

How hard stopping is also depends on the specific active ingredient — above all on its half-life (how long it stays in the body):

• Short half-life (e.g. paroxetine): the active ingredient disappears quickly from the body — the discontinuation syndrome is often more pronounced here
• Medium half-life (e.g. sertraline, citalopram, escitalopram): discontinuation symptoms possible, usually well manageable with slow tapering
• Long half-life (fluoxetine): the active ingredient breaks down very slowly on its own — stopping is often milder; fluoxetine is sometimes even used to make the switch from another SSRI easier
• Consequence: with short-acting active ingredients, especially slow tapering is important

These differences explain why some people barely notice stopping while others have clear symptoms — it is often down to the active ingredient. The doctor takes this into account when planning the tapering. More on the frequently prescribed SSRI sertraline.

9. What helps with discontinuation symptoms

If discontinuation symptoms occur during tapering, there are several ways to deal with them — always in consultation with the doctor:

• Slow down the pace: the most important step — delay the dose reduction or choose smaller steps
• Go back to the previous dose: with strong symptoms, briefly return to the last well-tolerated dose and then continue more slowly
• Patience and understanding: knowing that the symptoms are temporary and not dangerous takes away a lot of the fear
• General measures: enough sleep, exercise and stress reduction can support wellbeing
• Document symptoms: helps the doctor adjust the tapering

10. Supporting measures when stopping

Stopping is easier when it is accompanied by supporting measures:

• Psychotherapy: can lower the relapse risk and provide support when stopping — especially cognitive behavioural therapy.
• Choose a stable phase of life: if possible, do not schedule stopping during especially stressful times.
• Social support: involve those around you, communicate your plan.
• Healthy lifestyle: exercise, sleep, daily structure and social contacts have a stabilizing effect.
• Watch for early warning signs: know your own early signs of a worsening, in order to counteract in time.
• Regular contact with the doctor: discuss the stopping with support along the way.

Stopping is not just a question of dose reduction, but a process that affects the whole person. Good support — medical, psychotherapeutic and social — increases the chances of success and clearly lowers the relapse risk.

11. Common mistakes when stopping

These mistakes most often lead to problems when stopping:

• Abrupt stopping — the most common and most consequential mistake
• Tapering too quickly — the steps too large or too rapidly one after another
• Stopping on your own without medical supervision
• Stopping too early — before the improvement is sufficiently stable (relapse risk)
• Misreading discontinuation symptoms as a relapse — and therefore panicking unnecessarily or hastily going back to a higher dose
• Underestimating the last steps — the low doses in particular need small steps (hyperbolic tapering)
• Stopping during a stressful phase of life

The good news: almost all of these mistakes can be avoided with a slow, planned and medically supervised approach. Anyone who takes their time and is well prepared can usually stop SSRIs well.

12. When you need medical help

In the following situations, medical help is important:

• Before every stopping — to create a plan and choose the timing
• With strong or persistent discontinuation symptoms — to adjust the pace
• If a relapse is suspected of the depression or anxiety disorder
• If complaints return such as persistent low mood, sleep or anxiety problems
• If you are unsure whether it is discontinuation symptoms or a relapse

The risk of suicidal thoughts can be temporarily raised during antidepressant therapies and in transition phases — especially in younger people. Close support during such phases is important. Take every worsening seriously and speak about it.

13. How brite helps you when stopping

An SSRI stopping process often stretches over months, with many small reduction steps and the crucial task of telling discontinuation symptoms apart from a relapse. Here, structured documentation can make the difference:

Important: brite supports self-management and documentation, but does not replace the medical supervision of stopping. The documentation can, however, be very valuable for assessing the course together with the doctor.

Related topics